Clinical Trials Browser

Phase NA × Unknown × Alemtuzumab × Clear all

NCT00336206 2006-07-25

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

Phase NA Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell